Cocoon Biotech
Charles Koppel is an established entrepreneur who over a 30 year career has successfully started, bought, built and sold businesses across a range of industries from media, sports and entertainment to healthcare and natural resources, operating in diverse geographical regions including China, Europe, Latin America, Canada and the United States.
Charles has served as both Chairman and CEO of NASDAQ and TSX-v listed companies, is Chairman of a leading leisure and hospitality business, is a director and strategic advisor to a number of private health and wellness, leisure and FMCG companies both in Europe and North America, and is founder and CIO of a European based family office investment and advisory business.
Charles has a BSc in International Management & Finance and started his career at Merrill Lynch Europe.Z
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cocoon Biotech
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori).